Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin-HF: Insulin vs Non-Insulin in Heart Failure and Diabetes
NCT03665350Phase 2Terminated
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Nov 2018
- Primary completion
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoint: Change in blood glucose variability at 12 months. Started Nov 2018; status: terminated.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03665350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03665350.